Market Overview

Morning Market Losers


Premier Exhibitions, Inc. (NASDAQ: PRXI) tumbled 33.21 percent to $1.30. Premier Exhibitions reported a Q2 loss of $0.63 per share on sales of $6.7 million.

Cepheid (NASDAQ: CPHD) shares dipped 15.51 percent to $33.47 after the company published its preliminary results for its third quarter.

Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares fell 11.80 percent to $2.25 after the company announced that it has raised $8 million in private placement.

Renewable Energy Group Inc (NASDAQ: REGI) slipped 10.81 percent to $8.12 after the company lowered its Q3 forecast.

Colfax Corp (NYSE: CFX) dropped 5.89 percent to $27.79. Colfax reported downbeat Q3 results and announced a $100 million buyback program.

Intel Corporation (NASDAQ: INTC) shares dropped 3.31 percent to $30.98. Intel reported better-than-expected earnings for its third quarter on Tuesday.

ASML Holding NV (ADR) (NASDAQ: ASML) shares declined 2.43 percent to $85.19. ASML reported Q3 EPS of €0.75 on revenue €1.549 billion. The company issued a weak sales forecast.

JPMorgan Chase & Co. (NYSE: JPM) shares slipped 2.31 percent to $60.13 after the company reported weaker-than-expected results for the third quarter.

Physicians Realty Trust (NYSE: DOC) fell 2.22 percent to $15.21 after the company priced 13.75 million shares at $15 per share.

GoPro Inc (NASDAQ: GPRO) shares fell 2.11 percent to $27.38. Piper Jaffray downgraded GoPro from Overweight to Neutral.


Related Articles (CPHD + PRXI)

View Comments and Join the Discussion!

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at